Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bipolar Androgen Therapy plus Olaparib in mCRPC
NCT03516812Phase 2Completed
- Sponsor
- University of Washington
- Start
- Aug 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in prostate adenocarcinoma, sponsored by University of Washington. Started Aug 2018; status: completed.
02
Drugs
olaparib
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT03516812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03516812.